Exact Mass: 440.11389260000004
Exact Mass Matches: 440.11389260000004
Found 354 metabolites which its exact mass value is equals to given mass value 440.11389260000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Candesartan
Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is administered orally as the prodrug, candesartan cilexetil, which is rapidly converted to its active metabolite, candesartan, during absorption in the gastrointestinal tract. Candesartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Candesartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 79 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2804 CONFIDENCE standard compound; INTERNAL_ID 2137 CONFIDENCE standard compound; INTERNAL_ID 8182 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3]. Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3].
Ginkgolide C
C20H24O11 (440.13185539999995)
Ginkgolide C is found in fats and oils. Ginkgolide C is a bitter principle from Ginkgo biloba (ginkgo). Bitter principle from Ginkgo biloba (ginkgo). Ginkgolide C is found in ginkgo nuts and fats and oils. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease.
Hallactone B
A diterpenoid that is a organic heterohexacyclic compound consisting of lactone and epoxide ring systems. It is isolated from Podocarpus macrophyllus.
1S,3R-Rsl3
C23H21ClN2O5 (440.11389260000004)
S-[(Z)-N-hydroxy(4-hydroxyphenyl)acetimidoyl]glutathione
Aminopterin
Aminopterin Syndrome Sine Aminopterin (ASSA, OMIM 600325) is an embryopathy caused by maternal treatment with the olic acid antagonist aminopterin has been recognized since 1952 when aminopterin was used as an abortifacient. The characteristic phenotype of the children who survived infancy after having been exposed to aminopterin or its methyl derivative, methotrexate, in early pregnancy included a very unusual facies, skull anomalies, and skeletal defects.(OMIM). Aminopterin is an antimetabolite drug used in treatment of cancer and autoimmune diseases. It acts by inhibiting the metabolism of folic acid. - Wikipedia. The effects of the drug on intracellular metabolic processes, due to the inhibitory action on the enzyme dihydrofolate reductase, show that the result of this inhibition is more complex and is not limited to blockade of the reduction of folic acid alone. Although rescue methods are important in prevention of lethal effects of methotrexate, some metabolic pathways are insufficiently rescued, resulting in toxic reactions following methotrexate administration.(PMID 6398629). Aminopterin Syndrome Sine Aminopterin (ASSA, OMIM 600325) is an embryopathy caused by maternal treatment with the olic acid antagonist aminopterin has been recognized since 1952 when aminopterin was used as an abortifacient. The characteristic phenotype of the children who survived infancy after having been exposed to aminopterin or its methyl derivative, methotrexate, in early pregnancy included a very unusual facies, skull anomalies, and skeletal defects.(OMIM);
3,5-Dihydroxyphenyl 1-O-(6-O-galloyl-beta-D-glucopyranoside)
C19H20O12 (440.09547200000003)
3,5-Dihydroxyphenyl 1-O-(6-O-galloyl-beta-D-glucopyranoside) is found in green vegetables. 3,5-Dihydroxyphenyl 1-O-(6-O-galloyl-beta-D-glucopyranoside) is isolated from commercial rhubarb (Rheum species). Isolated from commercial rhubarb (Rheum subspecies). 3,5-Dihydroxyphenyl 1-O-(6-O-galloyl-beta-D-glucopyranoside) is found in green vegetables.
Propylene glycol alginate
Propylene glycol alginate is a stabiliser, emulsifier, thickener, formulation aid, surface active agent and flavouring adjunct or adjuvant for foodstuffs Propylene glycol alginate (PGA) is an emulsifier, stabilizer, and thickener used in food products. It is a food additive with E number E405. Chemically, propylene glycol alginate is an ester of alginic acid, which is derived from kelp. Some of the carboxyl groups are esterified with propylene glycol, some are neutralized with an appropriate alkali, and some remain free. Stabiliser, emulsifier, thickener, formulation aid, surface active agent and flavouring adjunct or adjuvant for foodstuffs
Isolariciresinol sulfate
Azobilirubin
Butyrolactone derivative
2,2-Dimethylpropanoyloxymethyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3R)-5-oxopyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
C20H28N2O7S (440.16171380000003)
Metreton
Ginkgolide
C20H24O11 (440.13185539999995)
ginkgolide-C is a natural product found in Ginkgo biloba with data available. See also: Ginkgo (part of). Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease.
9,11-Dihydroxy-2,3,6-trimethoxy-8-prenhyl-6a,12a-didehydrorotenone
Tetrahydroswertianolin
C20H24O11 (440.13185539999995)
A xanthone glycoside that is the 1,2,3,4-tetrahydro derivaive of swertianolin (the S,4R-stereoisomer). It is isolated from Swertia japonica and shows hepatoprotective properties.
3,5,8-Trimethoxy-3,4-methylenedioxy-7-prenyloxyflavone
6a,12b-Dihydro-3,10,11,12-tetrahydroxy-6-(3,4,5-trihydroxyphenyl)-[2]benzopyrano[3,4-c]benzopyran-8(6H)-one
Amurensisin
8,9-Dimethoxy-2-(2-phenyldiazenyl)-3-(2-thienyl)-5,6-dihydropyrrolo[2,1-a]isoquinoline-1-carbonitrile
N-(tert-Butyl)-2-[2-(2,4-dichlorophenoxy)acetyl]decahydroisoquinoline-3-carboxamide
C22H30Cl2N2O3 (440.16333699999996)
(8Z)-2,15-dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-3(30),4,6,8,10(29),11,13,16(21),17,19,25,27-dodecaene-4,5,17-triol 1
(20S)-14-oxapentacyclo[20.2.2.210,13.115,19.02,7]nonacosa-1(24),2(7),3,5,10(29),11,13(28),15,17,19(27),22,25-dodecaene-5,16,20,24-tetrol
CONFIDENCE Predicted
(E)-2-phenylmethylene-3-methoxy-4-[(2,3-diphenylpropionic acid methyl ester)-3-yl]-5-oxo-2(2H)-furylidene|isoravenelone methyl ester
(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano<3,4-c>-2-benzopyran-1-one|(2R,3S,10S)-7,8,9,13-tetrahydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-trans-3,4-cis-2,3,10-trihydrobenzopyrano[3,4-c]-2-benzopyran-1-one|(5鈥樎?Hydroxy-2R,3S,4S)-6-(3,4-Dihydroxyphenyl)-6alpha,12b-dihydro-3,10,11,12-tetrahydroxy[2]benzopyrano[3,4-c][1]benzopyran-8(6H)-one
3,5,8-Tri-Me,3,4-methylene ether,7-O-(3-methyl-2-butenyl)-Gossypetin
5-O-beta-D-glucopyranosyl-2,3-dihydrooroselol|peucedanoside B
C20H24O11 (440.13185539999995)
3-O-(3,4-dihydroxy-trans-cinnamoyl)-4-O-malonyl-quinic acid
C19H20O12 (440.09547200000003)
(2E)-3,4-dimethoxycinnamyl 3-(3,4-diacetoxyphenyl)acrylate
4-O-(E)-caffeoyl-5-O-malonylquinic acid|dihydroxy-5-carboxyacetoxy-4-[(E)-3-(3,4-dihydroxyphenyl)acryloyloxy]cyclohexanecarboxylic acid
C19H20O12 (440.09547200000003)
3-O-malonyl-5-O-(E)-caffeoylquinic acid|dihydroxy-3-carboxyacetoxy-5-[(E)-3-(3,4-dihydroxyphenyl)acryloyloxy]cyclohexanecarboxylic acid
C19H20O12 (440.09547200000003)
19,20-alpha-epoxy-12,15-dihydroxy-11-methoxyicajine
1-caffeoyl-6-tuliposide A|1-O-caffeoyl-6-O-(4-hydroxy-2-methylenebutyroyl)-beta-D-glucopyranose
C20H24O11 (440.13185539999995)
(6-cis-p-coumaroyl)-3-O-beta-D-glucopyranosyl-2-deoxy-D-ribono-gamma-lactone
C20H24O11 (440.13185539999995)
5,7,5-trimethoxy-6-(3-hydroxy-3-methyl-trans-but-1-enyl)-3,4-methylenedioxy flavone
3,10-diacetoxy-1,2;8,9-diepoxy-2,3,6a,7,9,10,13a,14-octahydro-1H,8H-7a,14a-cyclo-pyrazino[1,2-a;4,5-a]diindole-6,13-dione|O,O-diacetyl-scabrosine|Scabrosin-4,4-diacetat
O4-[O4,O6-((Xi)-1-Carboxy-aethyliden)-beta-D-galactopyranosyl]-3,6-anhydro-L-galactose-dimethylacetal|O4-[O4,O6-((Xi)-1-carboxy-ethylidene)-beta-D-galactopyranosyl]-3,6-anhydro-L-galactose-dimethylacetal
3-O-(6-O-galloyl)-beta-D-glucopyranosylmaltol
C19H20O12 (440.09547200000003)
JGB1741
JGB1741 (ILS-JGB-1741) is a potent and specific SIRT1 activity inhibitor with an IC50 of ～15 μM. JGB1741 is a weak SIRT2 and SIRT3 inhibitor with an all IC50>100 μM. JGB1741 increases the acetylated p53 levels leading to p53-mediated apoptosis with modulation of Bax/Bcl2 ratio, cytochrome c release and PARP cleavage. JGB1741 has the potential for breast cancer research[1].
candesartan
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2137 Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3]. Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3].
(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid
methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
Aminopterin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists
methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
(1S,3R,6R,7S,8S,9R,10S,13S,16S,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione
C20H24O11 (440.13185539999995)
Ginkgolide C
C20H24O11 (440.13185539999995)
Annotation level-1 Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease.
7,8,19,20-Tetrahydro-15,18-etheno-2,6:9,13-dimetheno-1,14-benzodioxacyclodocosin-11,12,24-triol
CONFIDENCE Predicted
(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid [IIN-based on: CCMSLIB00000845225]
(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid [IIN-based: Match]
methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate [IIN-based on: CCMSLIB00000846943]
methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate [IIN-based: Match]
methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate [IIN-based on: CCMSLIB00000846940]
(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid [IIN-based on: CCMSLIB00000845223]
methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate_major
(1S,3R,6R,7S,8S,9R,10S,13S,16S,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione_major
C20H24O11 (440.13185539999995)
(1S,3R,6R,7S,8S,9R,10S,13S,16S,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,?.0?,¹¹.0¹³,¹?]nonadecane-5,15,18-trione
C20H24O11 (440.13185539999995)
Cys Cys Cys Ile
C15H28N4O5S3 (440.12217580000004)
Cys Cys Cys Leu
C15H28N4O5S3 (440.12217580000004)
Cys Cys Asp Thr
C14H24N4O8S2 (440.10355039999996)
Cys Cys Glu Ser
C14H24N4O8S2 (440.10355039999996)
Cys Cys Ile Cys
C15H28N4O5S3 (440.12217580000004)
Cys Cys Leu Cys
C15H28N4O5S3 (440.12217580000004)
Cys Cys Ser Glu
C14H24N4O8S2 (440.10355039999996)
Cys Cys Thr Asp
C14H24N4O8S2 (440.10355039999996)
Cys Asp Cys Thr
C14H24N4O8S2 (440.10355039999996)
Cys Asp Phe Gly
Cys Asp Gly Phe
Cys Asp Thr Cys
C14H24N4O8S2 (440.10355039999996)
Cys Glu Cys Ser
C14H24N4O8S2 (440.10355039999996)
Cys Glu Ser Cys
C14H24N4O8S2 (440.10355039999996)
Cys Phe Asp Gly
Cys Phe Gly Asp
Cys Gly Asp Phe
Cys Gly Phe Asp
Cys Gly Met Met
C15H28N4O5S3 (440.12217580000004)
Cys Ile Cys Cys
C15H28N4O5S3 (440.12217580000004)
Cys Leu Cys Cys
C15H28N4O5S3 (440.12217580000004)
Cys Met Gly Met
C15H28N4O5S3 (440.12217580000004)
Cys Met Met Gly
C15H28N4O5S3 (440.12217580000004)
Cys Met Ser Thr
Cys Met Thr Ser
Cys Ser Cys Glu
C14H24N4O8S2 (440.10355039999996)
Cys Ser Glu Cys
C14H24N4O8S2 (440.10355039999996)
Cys Ser Met Thr
Cys Ser Thr Met
Cys Thr Cys Asp
C14H24N4O8S2 (440.10355039999996)
Cys Thr Asp Cys
C14H24N4O8S2 (440.10355039999996)
Cys Thr Met Ser
Cys Thr Ser Met
Asp Cys Cys Thr
C14H24N4O8S2 (440.10355039999996)
Asp Cys Phe Gly
Asp Cys Gly Phe
Asp Cys Thr Cys
C14H24N4O8S2 (440.10355039999996)
Asp Phe Cys Gly
Asp Phe Gly Cys
Asp Gly Cys Phe
Asp Gly Phe Cys
Asp Gly Ser Tyr
C18H24N4O9 (440.15432139999996)
Asp Gly Tyr Ser
C18H24N4O9 (440.15432139999996)
Asp Ser Gly Tyr
C18H24N4O9 (440.15432139999996)
Asp Ser Tyr Gly
C18H24N4O9 (440.15432139999996)
Asp Thr Cys Cys
C14H24N4O8S2 (440.10355039999996)
Asp Tyr Gly Ser
C18H24N4O9 (440.15432139999996)
Asp Tyr Ser Gly
C18H24N4O9 (440.15432139999996)
Glu Cys Cys Ser
C14H24N4O8S2 (440.10355039999996)
Glu Cys Ser Cys
C14H24N4O8S2 (440.10355039999996)
Glu Ser Cys Cys
C14H24N4O8S2 (440.10355039999996)
Phe Cys Asp Gly
Phe Cys Gly Asp
Phe Asp Cys Gly
Phe Asp Gly Cys
Phe Gly Cys Asp
Phe Gly Asp Cys
Gly Cys Asp Phe
Gly Cys Phe Asp
Gly Cys Met Met
C15H28N4O5S3 (440.12217580000004)
Gly Asp Cys Phe
Gly Asp Phe Cys
Gly Asp Ser Tyr
C18H24N4O9 (440.15432139999996)
Gly Asp Tyr Ser
C18H24N4O9 (440.15432139999996)
Gly Phe Cys Asp
Gly Phe Asp Cys
Gly Met Cys Met
C15H28N4O5S3 (440.12217580000004)
Gly Met Met Cys
C15H28N4O5S3 (440.12217580000004)
Gly Ser Asp Tyr
C18H24N4O9 (440.15432139999996)
Gly Ser Tyr Asp
C18H24N4O9 (440.15432139999996)
Gly Tyr Asp Ser
C18H24N4O9 (440.15432139999996)
Gly Tyr Ser Asp
C18H24N4O9 (440.15432139999996)
Ile Cys Cys Cys
C15H28N4O5S3 (440.12217580000004)
Leu Cys Cys Cys
C15H28N4O5S3 (440.12217580000004)
Met Cys Gly Met
C15H28N4O5S3 (440.12217580000004)
Met Cys Met Gly
C15H28N4O5S3 (440.12217580000004)
Met Cys Ser Thr
Met Cys Thr Ser
Met Gly Cys Met
C15H28N4O5S3 (440.12217580000004)
Met Gly Met Cys
C15H28N4O5S3 (440.12217580000004)
Met Met Cys Gly
C15H28N4O5S3 (440.12217580000004)
Met Met Gly Cys
C15H28N4O5S3 (440.12217580000004)
Met Ser Cys Thr
Met Ser Thr Cys
Met Thr Cys Ser
Met Thr Ser Cys
Ser Cys Cys Glu
C14H24N4O8S2 (440.10355039999996)
Ser Cys Glu Cys
C14H24N4O8S2 (440.10355039999996)
Ser Cys Met Thr
Ser Cys Thr Met
Ser Asp Gly Tyr
C18H24N4O9 (440.15432139999996)
Ser Asp Tyr Gly
C18H24N4O9 (440.15432139999996)
Ser Glu Cys Cys
C14H24N4O8S2 (440.10355039999996)
Ser Gly Asp Tyr
C18H24N4O9 (440.15432139999996)
Ser Gly Tyr Asp
C18H24N4O9 (440.15432139999996)
Ser Met Cys Thr
Ser Met Thr Cys
Ser Thr Cys Met
Ser Thr Met Cys
Ser Tyr Asp Gly
C18H24N4O9 (440.15432139999996)
Ser Tyr Gly Asp
C18H24N4O9 (440.15432139999996)
Thr Cys Cys Asp
C14H24N4O8S2 (440.10355039999996)
Thr Cys Asp Cys
C14H24N4O8S2 (440.10355039999996)
Thr Cys Met Ser
Thr Cys Ser Met
Thr Asp Cys Cys
C14H24N4O8S2 (440.10355039999996)
Thr Met Cys Ser
Thr Met Ser Cys
Thr Ser Cys Met
Thr Ser Met Cys
Tyr Asp Gly Ser
C18H24N4O9 (440.15432139999996)
Tyr Asp Ser Gly
C18H24N4O9 (440.15432139999996)
Tyr Gly Asp Ser
C18H24N4O9 (440.15432139999996)
Tyr Gly Ser Asp
C18H24N4O9 (440.15432139999996)
Tyr Ser Asp Gly
C18H24N4O9 (440.15432139999996)
Tyr Ser Gly Asp
C18H24N4O9 (440.15432139999996)
His-Tyr-OH
3,5-Dihydroxyphenyl 1-O-(6-O-galloyl-b-D-glucopyranoside)
C19H20O12 (440.09547200000003)
Dricoid
b-D-Glucopyranoside, phenyl1-thio-, 2,3,4,6-tetraacetate
(4-CHLOROBENZYL)TRIPHEYLPHOSPHONIUM TETRAFLUOROBORATE
(4R)-5-(8-azaspiro[4.5]decan-8-yl)-4-[(3,5-dichlorobenzoyl)amino]-5-oxopentanoic acid
C21H26Cl2N2O4 (440.12695360000004)
2-[[4-[(2-cyanoethyl)(2-phenoxyethyl)amino]phenyl]azo]-5-nitrobenzonitrile
4-[[4-(aminocarbonyl)phenyl]azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide
C25H20N4O4 (440.14844800000003)
2-((4-METHOXYPHENYL)AMINO)-1-(2-(TRIFLUOROMETHYL)BENZYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE
1,4-bis(4-phenylphenyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-3,6-dione
3-hydroxy-4-[(2-methyl-5-nitrophenyl)azo]-N-(o-tolyl)naphthalene-2-carboxamide
C25H20N4O4 (440.14844800000003)
Phenyl 2,3,4,6-Tetra-O-acetyl-1-thio-a-D-mannopyranoside
sodium 2-hydroxy-3-[3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propoxy]propane-1-sulphonate
C13H33NaO7SSi3 (440.11524280000003)
phenyl 2,3,4,6-tetra-o-acetyl-1-thio-beta-d-galactopyranoside
1-[(4-chlorophenyl)-phenylmethyl]-4-(4-methylphenyl)sulfonylpiperazine
(3β)-17-Iodoandrosta-5,16-dien-3-yl acetate
C21H29IO2 (440.12122039999997)
Benzonitrile, 4-[4-[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]-1-piperazinyl]-
C22H18Cl2N4O2 (440.08067479999994)
1-METHYL-3-TRIFLUOROMETHYL-5-TRIBUTYLSTANNYLPYRAZOLE
4-Thiazolidinecarboxylic acid, 3-[[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]acetyl]-2,2-dimethyl-, (4R)-
Ravoxertinib
C21H18ClFN6O2 (440.11637299999995)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C174048 - ERK Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Ravoxertinib (GDC-0994) is an orally active ERK kinase inhibitor with an IC50 of 6.1 nM and 3.1 nM for ERK1 and ERK2, respectively.
3-(N-Morpholino)propanesulfonic acid hemisodium salt
Bis(indenyl)dimethylhafnium(IV)
(C9H7)2Hf(CH3)2 (440.10305300000005)
GSK 2018682
C22H21ClN4O4 (440.12512560000005)
(S)-2-[(4-nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid isopropyl ester
N-(5-METHYLISOXAZOL-3-YL)-4-(3-(3-(TRIFLUOROMETHYL)PHENYL)UREIDO)BENZENESULFONAMIDE
C18H15F3N4O4S (440.07660660000005)
(4Z)-4-[(5-carbamoyl-2-methoxyphenyl)hydrazinylidene]-3-oxo-N-phenylnaphthalene-2-carboxamide
C25H20N4O4 (440.14844800000003)
(4Z)-4-[[2-methoxy-5-(phenylcarbamoyl)phenyl]hydrazinylidene]-3-oxonaphthalene-2-carboxamide
C25H20N4O4 (440.14844800000003)
Prednisolone phosphate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(r)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-4-methyl-1,4,6,7-tetrahydro-5h-[1,2,3]triazolo[4,5-c]pyridin-5-yl)methanone
Ozanimod Hydrochloride
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators C308 - Immunotherapeutic Agent
1-(2,4-dichlorophenyl)-6-methyl-N-(1-piperidinyl)-4H-indeno[1,2-c]pyrazole-3-carboxamide
2-Benzofurancarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
C25H16N2O4S (440.08307360000003)
2-oxo-N-[2-[(2-phenyl-1H-indol-3-yl)thio]ethyl]-1-benzopyran-3-carboxamide
2-[[(3,4-dimethoxyphenyl)-oxomethyl]amino]-N-(2-furanylmethyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
3-{2,6,8-Trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}propyl dihydrogen phosphate
C13H21N4O11P (440.09444060000004)
(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
C17H18Cl2N6O4 (440.07665280000003)
N2-({[(4-Bromophenyl)methyl]oxy}carbonyl)-N1-[(1S)-1-formylpentyl]-L-leucinamide
C20H29BrN2O4 (440.13105740000003)
(4r)-N-[4-({[2-(Dimethylamino)ethyl]amino}carbonyl)-1,3-Thiazol-2-Yl]-4-Methyl-1-Oxo-2,3,4,9-Tetrahydro-1h-Beta-Carboline-6-Carboxamide
3-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}propyl dihydrogen phosphate
C13H21N4O11P (440.09444060000004)
3-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}propyl dihydrogen phosphate
C13H21N4O11P (440.09444060000004)
3-{2,6,8-Trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-YL}propyl dihydrogen phosphate
C13H21N4O11P (440.09444060000004)
2,2-Dimethylpropanoyloxymethyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3R)-5-oxopyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
C20H28N2O7S (440.16171380000003)
(2S)-2-amino-5-[[(1R)-1-carboxy-2-[(1,2,6-trimethyl-3,5-dioxopyrazolo[1,2-a]pyrazol-7-yl)methylsulfanyl]ethyl]amino]-5-oxopentanoic acid
4-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-3-propyl-1H-pyrrol-2-yl]diazenyl]benzenesulfonic acid
3-(2-chlorophenyl)-6-(3-cyclopentyloxy-4-methoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
C22H21ClN4O2S (440.10736760000003)
3-[4-[(5Z)-5-[(4-methylphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid
C22H20N2O4S2 (440.08644400000003)
6-[[4-(3,4-dihydro-2H-quinolin-1-ylsulfonyl)anilino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid
2,6-difluoro-N-[2-[3-[(2-fluorophenyl)methylthio]-1-indolyl]ethyl]benzamide
C24H19F3N2OS (440.11701200000005)
4,5-Dimethoxy-2-[[1-oxo-2-[(3,5,8-trimethyl-2-quinolinyl)thio]ethyl]amino]benzoic acid
2-(3,5-Dinitrophenyl)-3-(2-phenylethyl)imidazo[4,5-b]quinoxaline
2-[N-(benzenesulfonyl)-4-ethoxyanilino]-N-(2-methoxyphenyl)acetamide
2-[[4-(2,5-dimethylphenyl)-5-(2-methyl-3-furanyl)-1,2,4-triazol-3-yl]thio]-N-(5-methyl-1,3,4-thiadiazol-2-yl)acetamide
(1S,5R)-3-[(6-chloro-7-hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)acetyl]-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one
C23H21ClN2O5 (440.11389260000004)
(1R,9S,10S,11S)-5-(3-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-(1,3-thiazol-2-yl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-5-(3-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-(1,3-thiazol-2-yl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
3-chloro-N-[(2S,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
3-chloro-N-[(2R,3R,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
3-chloro-N-[(2R,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
3-chloro-N-[(2S,3S,6R)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
3-chloro-N-[(2R,3S,6S)-6-[2-(ethylsulfonylamino)ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
[8-(2-hydroxy-1-sulooxypropan-2-yl)-2-oxo-8,9-dihydrouro[2,3-h]chromen-9-yl] (E)-2-methylbut-2-enoate
(2-hydroxy-2-{9-[(3-methylbut-2-enoyl)oxy]-2-oxo-2H,8H,9H-furo[2,3-h]chromen-8-yl}propoxy)sulfonic acid
(2-{9-hydroxy-2-oxo-2H,8H,9H-furo[2,3-h]chromen-8-yl}-2-[(3-methylbut-2-enoyl)oxy]propoxy)sulfonic acid
(1R,3R,8S,9R,10S,13S,16S,17R)-8-Tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione
C20H24O11 (440.13185539999995)
2-amino-5-[[3-[(Z)-C-benzyl-N-hydroxycarbonimidoyl]sulfanyl-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
(1S,3R,6R,7S,8S,9R,10S,11R,12S,13S,16S,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione
C20H24O11 (440.13185539999995)
(1S,3R,6R,7S,8S,9R,10S,13S,16S,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0(1),(1)(1).0(3),.0,(1)(1).0(1)(3),(1)]nonadecane-5,15,18-trione
C20H24O11 (440.13185539999995)
(1R,6R,7S,8S,9S,10S,11R,12R,13S,16S,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione
C20H24O11 (440.13185539999995)
(1S,3R,6R,7S,8S,9R,10S,11R,13S,16S,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione
C20H24O11 (440.13185539999995)
(1R,6R,7R,8S,9S,10S,11R,12R,13S,16S,17R)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione
C20H24O11 (440.13185539999995)
3,5-Dihydroxyphenyl 1-O-(6-O-galloyl-beta-D-glucopyranoside)
C19H20O12 (440.09547200000003)
(1R,3S)-2-(2-chloro-1-oxoethyl)-1-(4-methoxycarbonylphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-3-carboxylic acid methyl ester
C23H21ClN2O5 (440.11389260000004)
(E/Z)-ZINC09659342
(E/Z)-ZINC09659342 is an inhibitor of Lbc-RhoA interaction[1].
AZD4747
C24H22ClFN2O3 (440.13029040000004)
AZD4747 is a selective, blood-brain barrier-permeable mutant GTPase KRASG12C inhibitor. AZD4747 has the potential to study cancer[1].
JP1302 dihydrochloride
JP1302 dihydrochloride is a potent, selective, high affinity antagonist of the α2C-adrenoceptor, with a Kb of 16 nM and a Ki of 28 nM for the human α2C-receptor. JP1302 dihydrochloride shows antidepressant and antipsychotic-like effects. JP1302 dihydrochloride can be used for neuropsychiatric disorders and renal dysfunction research[1][2][3].
PF-06372865
PF-06372865 is an orally active, α2/α3/α5 subtype-selective GABAA positive allosteric modulator (PAM). PF-06372865 is a high affinity ligand at GABAA receptors containing α1/α2/α3/α5 subunits (Kis of 2.9 nM, 21 nM, 134 nM for α2, α1 PAM, α2 PAM, respectively), with low affinity for α4/α6 subunits. PF-06372865 can across the blood-brain barrier (BBB). PF-06372865 has anxiolytic activity and has the potential for epilepsy[1].
methyl (1r,2r,4r,5r,7r,11s,12s,15s,23r)-4,11-dihydroxy-18-methoxy-3-oxo-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17,19,21-triene-16-carboxylate
methyl (1r,2r,4s,5r,7r,11s,12s,15s,23r)-4,11-dihydroxy-18-methoxy-3-oxo-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17,19,21-triene-16-carboxylate
methyl (2r)-2-[(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-4-hydroxyphenyl)methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
(1r,3r,9r,10s,13s,16s,17r)-8-tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione
C20H24O11 (440.13185539999995)